Farname Inc. in collaboration with Iranian Society of Gynecology Oncology


1 Department of Obstetrics and Gynecology, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran

2 Department of pathology, faculty of medicine, Urmia university of medical sciences, Urmia, Iran

3 Department of radiology, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran.

4 4. Department of Midwifery, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran


Background: ovarian mature cystic teratomas (OMCTS) is one of the most common benign ovarian tumors. Most of MCTs can be diagnosed at ultrasonography (us). Due to heterogeneous composition and a variety of appearance, in some non-diagnostic imaging reports it is suggested that we evaluate some tumor markers (CA125 and CA19-9) to complement imaging modalities. According to previous investigation a single elevated CA 19-9 is in association of specific radio-pathologic features, such as size, torsion, bronchial glands, fat and teeth components. Here we are presenting three various cases of OMCT with different characteristics.
Case Presentation: case 1: asymptomatic, non-diagnose US, single- elevated CA19-9, smaller than in 10 cm with bronchial glands and fat component. Case 2: symptomatic, non-diagnostic US                                                         , normal CA19-9, larger than 10 cm with torsion and necrosis. Case 3: symptomatic, diagnostic US, single- elevated CA19-9, smaller than 10 cm, full of hair and Sebaceous material. Computer tomography (CT), in all of our cases was diagnostic based on OMCT. Apologia of pathologic pathway of elevated CA19-9 in both case 1 and 3 was in agreement with the result of previous investigations. In case 2, despite of large size and torsion, CA 19-9 level was low.
Conclusion: single- elevated CA 19-9 level in OMCTs could impact benign characteristics of this kind of tumor.


  1. 1. Huettner PC. Diagnostic Gynecologic and Obstetric Pathology. LWW; 2007. 2. DiSaia PJ, Creasman WT, Mannel RS, McMeekin DS, Mutch DG. Clinical gynecologic oncology e-book: Elsevier Health Sciences; 2017. 3. Sampaio J, Sarmento-Gonçalves I, Barros JM, Felix J, Tiago-Silva P. Mature Cystic Teratoma of Ovary with Abnormally High Levels of Ca19-9: A Case Report. Revista Brasileira de Ginecologia e Obstetrícia. 2016;38:365-7. 4. Benjapibal M, Boriboonhirunsarn D, Suphanit I, Sangkarat S. Benign cystic teratoma of the ovary: a review of 608 patients. Journal of the Medical Association of Thailand= Chotmaihet Thangphaet. 2000;83(9):1016-20. 5. Outwater EK, Siegelman ES, Hunt JL. Ovarian teratomas: tumor types and imaging characteristics. Radiographics. 2001;21(2):475-90. 6. Emin U, Tayfun G, Cantekin I, Ozlem UB, Umit B, Leyla M. Tumor markers in mature cystic teratomas of the ovary. Archives of gynecology and obstetrics. 2009;279(2):145-7. 7. Guerriero S, Mallarini G, Ajossa S, Risalvato A, Satta R, Mais V, et al. Transvaginal ultrasound and computed tomography combined with clinical parameters and CA‐125 determinations in the differential diagnosis of persistent ovarian cysts in premenopausal women. Ultrasound in Obstetrics and Gynecology: The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology. 1997;9(5):339-43. 8. Prodromidou A, Pandraklakis A, Loutradis D, Haidopoulos D. Is There a Role of Elevated CA 19-9 Levels in the Evaluation of Clinical Characteristics of Mature Cystic Ovarian Teratomas? A Systematic Review and Meta-analysis. Cureus. 2019;11(12). 9. Suh DS, Moon SH, Kim SC, Joo JK, Park WY, Kim KH. Significant simultaneous changes in serum CA19-9 and CA125 due to prolonged torsion of mature cystic teratoma of the ovary. World journal of surgical oncology. 2014;12(1):1-4. 10. Cho H-y, Kim K, Jeon Y-T, Kim Y-B, No JH. CA19-9 elevation in ovarian mature cystic teratoma: discrimination from ovarian cancer–CA19-9 level in teratoma. Medical science monitor: international medical journal of experimental and clinical research. 2013;19:230. 11. Cengiz H, Yasar L, Kaya C, Erkin M, Karakas S. The role of tumor markers in predicting mature cystic teratoma of the ovary. Gineco eu. 2012;8:158-61. 12. Kyung MS, Choi JS, Hong SH, Kim HS. Elevated CA 19-9 levels in mature cystic teratoma of the ovary. The International journal of biological markers. 2009;24(1):52-6. 13. Artunc Ulkumen B, Goker A, Pala HG, Ordu S. Abnormal elevated CA 19-9 in the dermoid cyst: a sign of the ovarian torsion? Case reports in obstetrics and gynecology. 2013;2013. 14. Kikkawa F, Ishikawa H, Tamakoshi K, Nawa A, Suganuma N, Tomoda Y. Squamous cell carcinoma arising from mature cystic teratoma of the ovary: a clinicopathologic analysis. Obstetrics & Gynecology. 1997;89(6):1017-22.